Skip to content

International Cholangiocarcinoma Research Network (ICRN)

The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.

The goal of ICRN is to accelerate the clinical translation of scientific discoveries to impact the lives of patients with cholangiocarcinoma.

If your industry or biotech company or organization is interested in partnering with the ICRN for the purposes of cholangiocarcinoma research and potential collaboration, please fill out the ICRN Industry Request for Engagement form.

ICRN Members Map


If you'd like more information about the ICRN, please contact Reham Abdel-Wahab.

ICRN Executive Committee


Milind Javle, MD


UT MD Anderson Cancer Center

Mitesh Borad, MD


Mayo Clinic, Arizona

John Bridgewater, PhD

University College London Hospital, UK


Laura Goff, MD

Biliary Cancer Alterations Predict Therapy Choice (BATCH)

Vanderbilt Ingram Cancer Center

Lipika Goyal

Lipika Goyal, MD

Genomic and Database Research WG Chair

Massachusetts General Hospital/Harvard University

Eugene J. Koay, MD, PhD

Radio-diagnostic and Radiation Oncology WG Chair

MD Anderson Cancer Center

Lawrence Kwong, PhD

Translation WG Chair

MD Anderson Cancer Center


Lewis Roberts, MB, ChB, PhD

Biorepository WG Chair

Mayo Clinic, Minnesota


Flavio Rocha, MD, FACS

Transplantation WG Chair

Virginia Mason Medical Center

Nilofer Saba Azad, M.D.

Immuno-oncology WG Chair

Johns Hopkins

Suebpong Tanasanvimon, MD

Bumrungrad International Hospital, Thailand

Advocacy Organization Hybrid Model for Advancing Research

WordPress Image Lightbox Plugin
Back to Top